Category: TSCA

March 25, 2026

EPA Proposes to Extend Compliance Dates for PCE and CTC TSCA Risk Management Rules

The U.S. Environmental Protection Agency (EPA) announced on March 24, 2026, that it will propose to extend certain compliance dates in the December 2024 final risk management rules for perchloroethylene (PCE) and carbon tetrachloride (CTC) under the Toxic Substances Control Act (TSCA). According to EPA, it continues to revise the final rules “to ensure they are practical and implementable to protect human health and the environment and maintain uses that power the U.S. economy.” Until EPA...
March 16, 2026

“TSCA CBI Re-substantiation: When, Why, and How to Prepare,” April 9, 2026, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

The Acta Group (Acta®) affiliate Bergeson & Campbell, P.C. (B&C®) is pleased to present "TSCA CBI Re-substantiation: When, Why, and How to Prepare." The Toxic Substances Control Act (TSCA) provides critical protections for commercially sensitive information related to a company’s business, processes, and chemicals. The 2016 Frank R. Lautenberg Chemical Safety for the 21st Century Act amendments included a ten-year cap on many confidential business information (CBI) claims, absent a...
March 9, 2026

HCPA’s 2026 Mid-year meeting, May 12-14, 2026, Washington, D.C.

HCPA’s Mid-Year Meeting focuses on the public policy issues that impact the household and commercial products industry. Attendees will engage with a dynamic network of CEOs, executive decision-makers, and thought leaders who have knowledge, solutions, and influence across the entire supply chain. Richard E. Engler, Ph.D. and Ryan N. Schmit will present “TSCA Roundup – Latest from EPA, Congress, and the Courts.” B&C is a proud sponsor....
March 9, 2026

TSCA Reform – 10 Years Later, June 10, 2026, Washington, D.C., and via livestream

Bergeson & Campbell, P.C. (B&C®), the Environmental Law Institute (ELI), and the George Washington University Milken Institute School of Public Health are pleased to present “TSCA Reform — 10 Years Later” on June 10, 2026. Leading panelists will reflect on the challenges and accomplishments since the implementation of the 2016 Lautenberg Amendments ten years ago and will discuss where the Toxic Substances Control Act stands today. ...
March 6, 2026

Senate Committee Examines Draft TSCA Legislation, Focusing on New Chemical Review

The Senate Committee on Environment and Public Works (EPW) held a hearing on a discussion draft of S.__, the Toxic Substances Control Act Fee Reauthorization and Improvement Act of 2026 (Discussion Draft) on March 4, 2026. The Committee’s one pager on the Discussion Draft notes that since the Toxic Substances Control Act (TSCA) was enacted 50 years ago, the U.S. Environmental Protection Agency’s (EPA) “approval process for new chemicals has not been substantively improved. The current...
January 27, 2026

House Subcommittee Holds Hearing on Legislation to Modernize TSCA

The House Committee on Energy and Commerce held a hearing on January 22, 2026, on “Chemicals in Commerce: Legislative Proposal to Modernize America’s Chemical Safety Law, Strengthen Critical Supply Chains, and Grow Domestic Manufacturing.” The hearing focused on a draft bill titled Discussion Draft of Legislation to Modernize the Toxic Substances Control Act (Discussion Draft). As reported in our January 17, 2026, memorandum, the Discussion Draft would impose sweeping changes to many of...
January 17, 2026

House Releases Discussion Draft of Legislation to Modernize TSCA

On January 15, 2026, the House Energy and Commerce Subcommittee on Environment announced it will hold a legislative hearing on January 22, 2026, entitled “Chemicals in Commerce: Legislative Proposal to Modernize America’s Chemical Safety Law, Strengthen Critical Supply Chains, and Grow Domestic Manufacturing.” The hearing will focus on a draft bill titled Discussion Draft of Legislation to Modernize the Toxic Substances Control Act (Discussion Draft).  While...
January 14, 2026

Christine M. Palermo, Ph.D., DABT Joins Bergeson & Campbell, P.C. and The Acta Group

Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®) are pleased to announce that Christine M. Palermo, Ph.D., DABT has joined our firms as Director of Regulatory Sciences. Dr. Palermo provides Acta clients with global strategy in chemical regulatory compliance, risk assessment, and product stewardship, assisting clients to commercialize new products and expand markets for existing product portfolios. Dr. Palermo deploys the extensive domestic and international experience she...
January 7, 2026

EPA Publishes Final Risk Evaluation for 1,3-Butadiene, Intends to Regulate 11 COUs to Protect Workers

The U.S. Environmental Protection Agency (EPA) announced on January 5, 2026, the availability of the final risk evaluation under the Toxic Substances Control Act (TSCA) for 1,3-butadiene. 91 Fed. Reg. 264. EPA states in its December 31, 2025, press release that it found “potential unreasonable health risks for workers who breathe in this chemical at their jobs in 11 specific industrial settings.” As required by TSCA, EPA will now develop a risk management rule to protect workers from the...
January 6, 2026

2026 Forecast for U.S. Federal and International Chemical Regulatory Policy

Download a PDF of the Forecast 2026. Bergeson & Campbell, P.C. (B&C®), its global consulting affiliate The Acta Group (Acta®), and consortia management affiliate B&C® Consortia Management, L.L.C. (BCCM) are pleased to share with you our Forecast 2026. Our distinguished global team of chemical experts worked hard to summarize our collective best guess on what to expect in the New Year regarding global industrial, agricultural, and biocidal chemical regulatory and policy...
January 5, 2026

What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2026, January 27, 2026, 11:00 a.m. – 12:00 p.m. (EST), via webinar

Register now to join The Acta Group (Acta®) and Bergeson & Campbell, P.C. (B&C®) for “What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2026,” a complimentary webinar offering our best-informed judgment as to the trends and key developments chemical industry stakeholders can expect in 2026. Each year, we devote an hour to addressing the key domestic chemical legal, legislative, and policy developments we describe in our Forecast...
December 12, 2025

Lynn L. Bergeson, Hallelujah, EPA Proposes to Narrow Scope of TSCA Section 8(a)(7) PFAS Reporting Rule, Chemical Processing, December 10, 2025.

On Nov. 13, 2025, the U.S. Environmental Protection Agency (EPA) proposed revisions (90 Fed. Reg. 50923) to the Toxic Substances Control Act (TSCA) Section 8(a)(7) regulation for reporting and recordkeeping requirements for perfluoroalkyl and polyfluoroalkyl substances (PFAS). This column summarizes the proposal and the reasons for it....
December 8, 2025

EPA Begins Public Comment Period on Updated Draft Risk Calculation Memorandum for Formaldehyde

On December 3, 2025, the U.S. Environmental Protection Agency (EPA) announced the availability of and solicited public comment on an Updated Draft Risk Calculation Memorandum (Draft Memorandum) to inform a revised draft risk evaluation for formaldehyde under the Toxic Substances Control Act (TSCA). 90 Fed. Reg. 55726. EPA states that after further consideration of comments raised during the scientific peer review process, it is reconsidering the use of certain hazard values in the formaldehyde...
November 25, 2025

EPA Publishes Default Values Used in New Chemical Risk Assessments under TSCA

On November 24, 2025, the U.S. Environmental Protection Agency (EPA) released the key default values that it uses in its risk assessments of new chemicals under the Toxic Substances Control Act (TSCA). EPA is making the assumptions available on its website in the New Chemicals Division Reference Library. EPA states that it expects the publication of the default values “to improve efficiency, reducing the likelihood that submissions need to be reworked or resubmitted.” According to EPA,...
November 20, 2025

EPA Preliminarily Determines that 1,2-Dichloroethane Poses Unreasonable Risk to Human Health and the Environment

On November 19, 2025, the U.S. Environmental Protection Agency (EPA) announced the availability of and requested comment on a draft risk evaluation under the Toxic Substances Control Act (TSCA) for 1,2-dichloroethane (Chemical Abstracts Service Registry Number® (CAS RN®) 107-06-2, also known as ethylene dichloride or EDC). 90 Fed. Reg. 52054. EPA notes that the purpose of risk evaluations under TSCA is to determine whether a chemical substance presents an unreasonable risk of injury to health...
November 13, 2025

EPA Proposes to Narrow Scope of TSCA Section 8(a)(7) PFAS Reporting Rule; Exemptions Would Include De Minimis Amounts, Imported Articles

On November 13, 2025, the U.S. Environmental Protection Agency (EPA) issued a proposed rule to amend the Toxic Substances Control Act (TSCA) Section 8(a)(7) regulation for reporting and recordkeeping requirements for perfluoroalkyl and polyfluoroalkyl substances (PFAS). 90 Fed. Reg. 50923. As reported in our October 3, 2023, memorandum, the final rule requires manufacturers (including importers) of PFAS and PFAS-containing articles in any year since 2011 through 2022 to report information...
November 3, 2025

HCPA 2025 Annual Meeting, December 7-10, 2025, Fort Lauderdale, FL

HCPA’s Annual Meeting engages on the public policy issues that impact the household and commercial products industry. Thought leaders will discuss legislative and regulatory issues, information related to product registrations, sustainability, and industry trends. Richard E. Engler, Ph.D. will present “TSCA Regulatory Update” during the Regulatory Affairs Council Program on December 9, 2025....
October 31, 2025

Senate Subcommittee Examines Beneficial Use and Regulation of Chemicals

On October 23, 2025, the Senate Environment and Public Works Subcommittee on Chemical Safety, Waste Management, Environmental Justice, and Regulatory Oversight held a hearing on “Examining the Beneficial Use and Regulation of Chemicals.” The Subcommittee heard from the following witnesses: Peter Huntsman, President and Chief Executive Officer (CEO), Huntsman Corporation (written testimony); Dr. Gwen Gross, Senior Technical Fellow, The Boeing Company (written testimony); and Dr. Tracey...